ARS Pharmaceuticals Statistics
NASDAQ: SPRYHealthcareBiotechnologyUSD
4.36+0.065 (+1.51%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ARS Pharmaceuticals by the numbers
ARS Pharmaceuticals has a market capitalization of $433.6 million based on 99.45M shares outstanding. With trailing EPS of $-2.18, ARS Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.2% below its 50-day average and 45.8% below its 200-day average.
Average daily trading volume is 1.86M shares, or about $8.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SPRY valuation vs. peer median
| Metric | SPRY | Peer median | Difference |
|---|---|---|---|
| Market cap | $433.59M | $432.12M | +0% |
| Avg. volume | 1.86M | 382.22K | +386% |
Peer median across 8 companies: RZLT, DMAC, EDIT, AGMB, PRTA, ENTX, YDES, TECX.
Valuation
- Market cap
- $433.59M
- EPS (TTM)
- $-2.18
- Shares outstanding
- 99.45M
Price and trading
- Previous close
- 4.30
- Open
- 4.24
- Day range
- 4.20 – 4.40
- 52-week range
- 3.99 – 13.15
- 52-week change
- -57.79%
- Beta
- —
- Volume
- 1.30M
- Average volume
- 1.86M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 433.59M
- Forward Pe
- -4.86
- Eps
- -2.18
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.15
- Week52 Low
- 3.99
- Avg Volume
- 1.86M
- Shares Outstanding
- 99.45M
- Ma50
- 5.20
- Ma200
- 8.05
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -66.84%
- Pct From52w Low
- 9.41%